Researchers in a 2025 study found that women with RPL show distinct immune-related gene activity in their endometrium, identifying a possible molecular signature that could help diagnose or personalize treatment for RPL in the future.
Researchers in 2024 detailed a case report of a patient with recurrent implantation failure as a result of bacterial contamination, which was resolved after removal of the zona.